AJP - Renal Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F1134-F1141, 2008. First published August 13, 2008; doi:10.1152/ajprenal.00104.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/4/F1134    most recent
00104.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sánchez-Lozada, L. G.
Right arrow Articles by Johnson, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sánchez-Lozada, L. G.
Right arrow Articles by Johnson, R. J.

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia

Laura G. Sánchez-Lozada,1 Virgilia Soto,2 Edilia Tapia,1 Carmen Avila-Casado,2 Yuri Y. Sautin,3 Takahiko Nakagawa,3 Martha Franco,1 Bernardo Rodríguez-Iturbe,4 and Richard J. Johnson3

Departments of 1Nephrology and 2Pathology, Instituto Nacional de Cardiología Ignacio Chavez, Mexico City, Mexico; 3Department of Medicine/Nephrology, University of Florida, Gainesville, Florida; and 4Renal Service and Laboratory, Hospital Universitario and Instituto de Investigaciones Biomédicas, Maracaibo, Venezuela

Submitted 28 February 2008 ; accepted in final form 8 August 2008

Endothelial dysfunction is a characteristic feature during the renal damage induced by mild hyperuricemia. The mechanism by which uric acid reduces the bioavailability of intrarenal nitric oxide is not known. We tested the hypothesis that oxidative stress might contribute to the endothelial dysfunction and glomerular hemodynamic changes that occur with hyperuricemia. Hyperuricemia was induced in Sprague-Dawley rats by administration of the uricase inhibitor, oxonic acid (750 mg/kg per day). The superoxide scavenger, tempol (15 mg/kg per day), or placebo was administered simultaneously with the oxonic acid. All groups were evaluated throughout a 5-wk period. Kidneys were fixed by perfusion and afferent arteriole morphology, and tubulointerstitial 3-nitrotyrosine, 4-hydroxynonenal, NOX-4 subunit of renal NADPH-oxidase, and angiotensin II were quantified. Hyperuricemia induced intrarenal oxidative stress, increased expression of NOX-4 and angiotensin II, and decreased nitric oxide bioavailability, systemic hypertension, renal vasoconstriction, and afferent arteriolopathy. Tempol treatment reversed the systemic and renal alterations induced by hyperuricemia despite equivalent hyperuricemia. Moreover, because tempol prevented the development of preglomerular damage and decreased blood pressure, glomerular pressure was maintained at normal values as well. Mild hyperuricemia induced by uricase inhibition causes intrarenal oxidative stress, which contributes to the development of the systemic hypertension and the renal abnormalities induced by increased uric acid. Scavenging of the superoxide anion in this setting attenuates the adverse effects induced by hyperuricemia.

superoxide; glomerular hypertension; arteriolopathy; tempol; uric acid



Address for reprint requests and other correspondence: L. Gabriela Sánchez-Lozada, Dept. of Nephrology. INC Ignacio Chávez, Juan Badiano 1. 14080. Mexico City, Mexico (e-mail: lgsanchezlozada{at}gmail.com)




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Shimada, R. J. Johnson, W. S. May Jr, V. Lingegowda, P. Sood, T. Nakagawa, Q. C. Van, B. Dass, and A. A. Ejaz
A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome
Nephrol. Dial. Transplant., October 1, 2009; 24(10): 2960 - 2964.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.